Advancing an Inflammatory Subtype of Major Depression.
1Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta.
The American Journal of Psychiatry
|May 7, 2025
Summary
Chronic inflammation is linked to depression, particularly a subtype with specific symptoms like fatigue. Targeting inflammation may offer new precision treatments for this inflammatory depression subset.
Area of Science:
- Neuroscience
- Psychiatry
- Immunology
Background:
- Chronic inflammation is implicated in various disorders, including major depressive disorder.
- Inflammatory stimuli alter brain neurotransmitters and neurocircuits, contributing to depressive symptoms.
- Inflammatory cytokines blockade shows potential in reducing depressive symptoms.
Purpose of the Study:
- To identify and characterize an inflammatory subtype of depression.
- To explore the role of inflammation in specific depressive symptoms and treatment response.
- To inform precision medicine strategies in psychiatry.
Main Methods:
- Analysis of inflammatory biomarkers in individuals with depression.
- Correlation of biomarker levels with specific symptom profiles (neurovegetative symptoms).
- Assessment of biomarker association with antidepressant treatment response.
Main Results:
- Increased inflammatory biomarkers are associated with neurovegetative symptoms (anhedonia, fatigue, psychomotor slowing).
- Biomarkers predict response to certain antidepressant treatments.
- Elevated inflammatory markers are present only in a subgroup of depressed individuals, suggesting a distinct subtype.
Conclusions:
- A subset of depression patients exhibits inflammation-driven disease with unique symptoms and treatment responses.
- Identifying this inflammatory depression subtype is crucial for developing targeted immune-based therapies.
- This mechanism-based approach can refine psychiatric diagnostics and advance precision medicine.
Related Concept Videos
Depressive Disorders: MDD and Dysthymia
16
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
16
Depression: Overview
186
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
186
Depressive Disorders: Etiology
17
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
17
Stress and Mental Health
42
Chronic stress profoundly affects mental health, significantly influencing mood, behavior, and overall quality of life. Research closely links chronic stress with mental health conditions such as depression, anxiety, and substance use disorders. Ongoing exposure to stress can lead to physiological and psychological changes, initiating a cycle of emotional distress and maladaptive coping mechanisms.
Individuals with depression often experience challenges in both their personal and professional...
Individuals with depression often experience challenges in both their personal and professional...
42
Bipolar Disorder
29
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
29
Antidepressant Drugs: MAOIs and Other Agents
159
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
159


